CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase IIIB, Randomized, Observer-blind, Multicenter Study to Assess the Safety and Immunogenicity of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine to Healthy Subjects of 16-18 Years of Age
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04318548
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:47.396041+00:00
- Published At
- 2025-03-04T00:00:00+00:00
- Record Updated At
- 2025-03-04
- Results Posted At
- 2025-03-04
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Infections, Meningococcal"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-04"- protocolSection.identificationModule.nctId
"NCT04318548"- protocolSection.identificationModule.officialTitle
"A Phase IIIB, Randomized, Observer-blind, Multicenter Study to Assess the Safety and Immunogenicity of GSK\u0027s Meningococcal Group B Vaccine When Administered Concomitantly With GSK\u0027s Meningococcal MenACWY Conjugate Vaccine to Healthy Subjects of 16-18 Years of Age"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-03-04"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.